These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 2293858

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 44. DNA-ploidy in advanced gastric carcinoma is less heterogeneous than in early gastric cancer.
    Osterheld MC, Caron L, Demierre M, Laurini R, Bosman FT.
    Cell Oncol; 2004 Dec; 26(1-2):21-9. PubMed ID: 15371654
    [Abstract] [Full Text] [Related]

  • 45. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
    Collin F, Chassevent A, Bonichon F, Bertrand G, Terrier P, Coindra JM.
    Cancer; 1997 Jun 15; 79(12):2371-9. PubMed ID: 9191525
    [Abstract] [Full Text] [Related]

  • 46. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
    Yonemura Y, Miyazaki I.
    Rinsho Byori; 1990 Sep 15; 38(9):1053-8. PubMed ID: 2232266
    [Abstract] [Full Text] [Related]

  • 47. Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
    Gasińska A, Krzyszk wski T, Niemiec J, Adamczyk A, Skołyszewski J.
    Folia Histochem Cytobiol; 2000 Sep 15; 38(4):175-80. PubMed ID: 11185722
    [Abstract] [Full Text] [Related]

  • 48. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
    Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G, Morello V, Dardanoni G, Latteri MA, Colucci G, Tomasino RM, Gebbia N.
    Cancer; 2001 Jul 15; 92(2):294-302. PubMed ID: 11466682
    [Abstract] [Full Text] [Related]

  • 49. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
    Sugai T, Habano W, Jiao YF, Suzuki M, Takagane A, Nakamura S.
    Oncology; 2005 Jul 15; 68(4-6):548-57. PubMed ID: 16037688
    [Abstract] [Full Text] [Related]

  • 50. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A.
    Gynecol Oncol; 1995 Aug 15; 58(2):149-56. PubMed ID: 7622098
    [Abstract] [Full Text] [Related]

  • 51. [DNA ploidy in submucosal cancer of the stomach and its relationship to lymph node metastasis].
    Hashizume T, Yamaura T, Fukuda T, Sugihara S, Nakajima T, Nagamachi Y.
    Nihon Geka Gakkai Zasshi; 1991 Apr 15; 92(4):397-400. PubMed ID: 1870567
    [Abstract] [Full Text] [Related]

  • 52. Flow cytometric DNA measurement of gastric cancers. Clinico-pathological implication of DNA ploidy.
    Sasaki K, Takahashi M, Hashimoto T, Kawachnino K.
    Pathol Res Pract; 1989 Jun 15; 184(6):561-6. PubMed ID: 2780430
    [Abstract] [Full Text] [Related]

  • 53. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H, Rutgers DH, Jansen GH, Tulleken CA, van der Tweel I, Battermann JJ.
    Radiat Oncol Investig; 1997 Jun 15; 5(4):170-9. PubMed ID: 9327496
    [Abstract] [Full Text] [Related]

  • 54. DNA ploidy is a major prognostic factor in advanced gastric carcinoma--univariate and multivariate analysis.
    Haraguchi M, Watanabe A, Moriguchi S, Korenaga D, Maehara Y, Okamura T, Sugimachi K.
    Surgery; 1991 Nov 15; 110(5):814-9. PubMed ID: 1948649
    [Abstract] [Full Text] [Related]

  • 55. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ, van de Velde CJ, Caspers RJ, Moolenaar AJ, Hermans J.
    Cytometry; 1987 Mar 15; 8(2):225-34. PubMed ID: 3582068
    [Abstract] [Full Text] [Related]

  • 56. Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma?
    Filipe MI, Rosa J, Sandey A, Imrie PR, Ormerod MG, Morris RW.
    Hum Pathol; 1991 Apr 15; 22(4):373-8. PubMed ID: 2050371
    [Abstract] [Full Text] [Related]

  • 57. DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance.
    Abou-Rebyeh H, Al-Abadi H, Jonas S, Rotter I, Bechstein WO, Neuhaus P.
    Cancer Detect Prev; 2002 Apr 15; 26(4):313-9. PubMed ID: 12430636
    [Abstract] [Full Text] [Related]

  • 58. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
    Redkar AA, Balsara BR, Bhisey AN, Sampat MB, Mittra I.
    Indian J Med Res; 1992 Aug 15; 96():223-9. PubMed ID: 1428060
    [Abstract] [Full Text] [Related]

  • 59. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
    O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Allen D, Rubens RD, Richards MA.
    Br J Cancer; 1990 May 15; 61(5):671-4. PubMed ID: 2159768
    [Abstract] [Full Text] [Related]

  • 60. Clinical significance of DNA ploidy pattern in stage III gastric cancer.
    Sakusabe M, Kodama M, Sato Y, Kikuchi T, Koyama K.
    World J Surg; 1996 Jan 15; 20(1):27-31. PubMed ID: 8588408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.